Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

NCT00617370 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Adenocarcinoma of the Breast

Interventions

DRUG: epirubicin, cyclophosphamide, Paclitaxel,

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]